Evidence map›Paper›PMID 36466814›Full record

ArticleFrontiers in immunology2022

Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection.

Howard S Fox, Meng Niu, Brenda M Morsey, Benjamin G Lamberty, Katy Emanuel, Palsamy Periyasamy, Shannon Callen, Arpan Acharya, Gregory Kubik, James Eudy and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Primary Literature for Teaching Neuroimmunology - An Instructor's Resource.Journal of undergraduate neuroscience education : JUNE : a publication of FUN, Faculty for Undergraduate Neuroscience · 2024
    Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Howard S FoxDepartments of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Meng NiuGenetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.
Brenda M MorseyDepartments of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Benjamin G LambertyDepartments of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Katy EmanuelDepartments of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Palsamy PeriyasamyPharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Shannon CallenPharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Arpan AcharyaPharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Gregory KubikThe Genomics Core Facility, University of Nebraska Medical Center, Omaha, NE, United States.
James EudyGenetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.
Chittibabu GudaGenetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.
Shetty Ravi DyavarThe Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, NE, United States.
Courtney V FletcherThe Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, NE, United States.
Siddappa N ByrareddyPharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Shilpa BuchPharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
University of Nebraska Medical Center · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Heather Colleen Jensen-Smith · 2012 to 2026
$59.2M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI James Eudy · 1985 to 2026
$55.0M
Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUDA, CHITTIBABU · 2016 to 2025
$42.8M
Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S · 2000 to 2021
$37.7M
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey modelU01DA053624 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J, FOX, HOWARD S · 2021 to 2025
$8.2M
The brain as a SIV reservoir under suppressive cART potentiation by drugs of abuseR01DA043164 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., BYRAREDDY, SIDDAPPA N · 2016 to 2020
$3.8M
The Lymphoid Tissue Pharmacology of Antiretroviral DrugsR01AI124965 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FLETCHER, COURTNEY V · 2016 to 2020
$3.7M
NCI NIH HHS P30 CA036727NIAID NIH HHS R01 AI124965NIDA NIH HHS R01 DA043164NIDA NIH HHS U01 DA053624NIGMS NIH HHS P20 GM103427NIGMS NIH HHS U54 GM115458NIMH NIH HHS P30 MH062261
6 · The paper itself

Abstract

The twin pandemics of opioid abuse and HIV infection can have devastating effects on physiological systems, including on the brain. Our previous work found that morphine increased the viral reservoir in the brains of treated SIV-infected macaques. In this study, we investigated the interaction of morphine and SIV to identify novel host-specific targets using a multimodal approach. We probed systemic parameters and performed single-cell examination of the targets for infection in the brain, microglia and macrophages. Morphine treatment created an immunosuppressive environment, blunting initial responses to infection, which persisted during antiretroviral treatment. Antiretroviral drug concentrations and penetration into the cerebrospinal fluid and brain were unchanged by morphine treatment. Interestingly, the transcriptional signature of both microglia and brain macrophages was transformed to one of a neurodegenerative phenotype. Notably, the expression of osteopontin, a pleiotropic cytokine, was significantly elevated in microglia. This was especially notable in the white matter, which is also dually affected by HIV and opioids. Increased osteopontin expression was linked to numerous HIV neuropathogenic mechanisms, including those that can maintain a viral reservoir. The opioid morphine is detrimental to SIV/HIV infection, especially in the brain.

Indexed as

HIV InfectionsMorphineAnalgesics, OpioidAnimalsAnti-Retroviral AgentsBrainGene ExpressionMacacaOsteopontinAnalgesics, OpioidAnti-Retroviral AgentsMorphineOsteopontincentral nervous systemHIVmicroglianeuroHIVnonhuman primateopiateopioidSIV

Identifiers

PMID36466814
PMCPMC9709286
OpenAlexW4309308822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.